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ABSTRACT 
 
Hayes, Erika Robinson. THE EFFECTS OF POLYPHENOL RICH PEANUT SKIN 
DIETS ON WEIGHT GAIN, LIPID PROFILE, AND BLOOD CHEMISTRY IN RATS. 
(Advisor: Tracy Hanner), North Carolina Agricultural and Technical State University. 
 
 
Peanut skin is a by-product of the peanut processing industry that is typically 
disposed. However, peanut skin contains significant amounts of protein, lipids, dietary 
fiber and is rich in antioxidants such as phenolics. The objectives of this study were to (1) 
evaluate the overall impact of peanut skin consumption on the growth of young lab rats; 
(2) investigate the effects of peanut skin consumption on blood plasma cholesterol profile 
in laboratory rats; and (3) evaluate the effect of peanut skin consumption on the functions 
of major animal organs by measuring the changes of related biomarkers and gross 
pathology. Twenty five 7-week old female Sprague Dawley rats were randomly assigned 
to one of five groups. Each group was fed one of five different diets for 8 weeks. The 
diets were: G1- standard Purina 5001 rodent diet; G2- Purina-5001 + 1% cholesterol; G3- 
Purina-5001 + 1% cholesterol and 2.5% peanut skin, G4- Purina-5001 + 1% cholesterol 
and 5.0% peanut skin; and G5- Purina-5001 + 1% cholesterol and 10.0% peanut skin. In 
each group, the rat’s average food consumption and total body weight were measured 
weekly. The hematological parameters and lipid profile of blood were evaluated biweekly 
using pooled blood samples. At the time of euthanasia, the gross pathology of rats was 
performed and the brain, liver, heart, lung, kidney, and spleen were weighed and visually 
checked for abnormalities.  Results showed that rats in G2-G5 consumed more feed and 
gained more weight than rats in G1. Rats in G4 and G5 had lower triglycerides and total 
cholesterol than rats in G2. During the first few weeks, rats fed with the peanut skin diets 
 xiii 
had higher LDL and lower HDL than rats in G2. However, this trend reversed after 5 
weeks. Compared to G2, rats in G4 and G5 showed lower ALT, BUN and glucose levels, 
particularly at later feeding stages. Organs of rats in G2 were larger than the organs in 
other groups. This study suggests that long term consumption of diets containing  5% 
peanut skin may significantly lower the health risks associated with consuming a high 
cholesterol diet. 
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CHAPTER 1 
INTRODUCTION 
 
Peanut is an important crop and oil seed. The world’s peanut production was 34.4 
million metric tons in 2008-2009 and the United States is currently the third largest 
peanut producer (USDA, 2010). Peanut is a source of plant protein, dietary fiber, 
unsaturated fatty acids, B-vitamins, vitamin E, magnesium, copper and phosphorous. 
Numerous bioactive substances, including polyphenols are present in peanuts (Griel, 
Eissenstat, Juturu, Hsieh, & Kris-Etherton, 2004). Peanuts are widely used to produce 
peanut oil, peanut butter, peanut flour, peanut protein concentrate/isolate, and roasted 
peanut snacks. Peanuts are also used to develop infant formula and peanut milk. The food 
industry’s use of peanuts generates a significant amount of peanut skin, a by-product with 
little value, usually 2-3% of the total peanuts produced. It is estimated that world 
production of peanut skin is on the magnitude of 750,000 tons annually, with the only 
current market being low value animal feed applications (Sobolev & Cole, 2004). Peanut 
skin contains 16.6% oil, 12.32% protein and 2.83% ash (Nepote, Grosso, & Guzman, 
2002) and is typically used as animal feed or decomposed. Peanut skin is also rich in 
polyphenols such as catechins, A-type and B-type procyanidins (also called condensed 
tannins), some phenolic acids and reveratrols (Nepote, Grosso, & Guzman, 2002; Lou, 
Yamazaki, Sasaki, Uchida, Tanaka, & Oka, 1999; Yu, Ahmedna, Goktepe, & Dai, 2006).  
Polyphenols are secondary metabolites of plants and the most abundant 
antioxidants in the diet. Main dietary sources of polyphenols are fruits and plant derived 
beverages such as teas, fruit juices and wines.  Vegetables, cereals, chocolate and dry 
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legumes also contribute to intake of polyphenol (Scalbert, Johnson, & Saltmarsh, 2005). 
Numerous in-vitro and in-vivo studies show that dietary polyphenols have antioxidant, 
anticarcinogenic, cardiopreventive, and anti-inflammatory effects. Some polyphenols 
were reported to improve bone health, cognitive function, and to reduce postmenopausal 
symptoms. Epidemiological studies have shown that a diet rich in polyphenols is 
inversely associated with cardiovascular disease (Arts & Hollman, 2005). Fruits and 
vegetables rich in polyphenols may help to reverse hyperlipidemia, alter the 
atherogenicity of the LDL particle (Lampe, 1999) and protect the cholesterol in LDL 
from oxidation (Brouillard, George, & Fourgerousse, 1997). 
 Human studies have shown that diets rich in procyanidins decrease/inhibit lipid 
peroxidation of LDL cholesterol and increase free radical scavenging capacity (Natella, 
Belelli, Gentili, Ursini, & Scaccini, 2002; Fuhrman, Lavy, & Aviram, 1995). Studies in 
different cell lines, animal models and human epidemiological trials suggest a protective 
role of dietary polyphenols against different types of cancers. The in vitro antioxidant 
activity of peanut skin polyphenols, and their protective effect against lipid oxidation and 
bacterial growth in ground beef have been reported (Yu, Ahmedna, Goktepe, & Dai 
2006; Yu, Ahmedna, & Goktepe, 2010). However, the health benefits of peanut skin 
polyphenol in animal models have not been reported. 
The objectives of this study were to (1) evaluate the overall impact of peanut skin 
consumption on the growth of young lab rats; (2) investigate the effects of peanut skin 
consumption on blood plasma cholesterol profile in laboratory rats; and (3) evaluate the 
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effect of peanut skin consumption on the functions of major animal organs by measuring 
the changes of related biomarkers and gross pathology.   
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                                        CHAPTER 2 
LITERATURE REVIEW 
2.1 Diseases Associated with Hypercholesterolemia in Humans 
 Increased levels of dietary cholesterol can aid in the development of 
cardiovascular diseases. Cardiovascular diseases which include hypertension, 
atherosclerosis, myocarditis, and coronary heart disease are leading causes of death in the 
United States and the world. Elevated levels of the lipoprotein fractions, LDL, IDL and 
VLDL are regarded as atherogenic (prone to cause atherosclerosis). It was hypothesized 
that oxidation of LDL modifies the LDL particles. These modified particles are then 
taken by macrophages inside the arterial wall and form arthosclerotic plague (Zock & 
Katan, 1998).  Atherosclerosis may occur when plaque made up of cholesterol, calcium, 
and other fats build up on the inner surface of blood vessels. Plaque grows thick leading 
to a narrowing of blood vessels and restriction of blood flow. High cholesterol levels 
have been associated with coronary artery plaque formation in coronary heart disease. A 
heart attack may occur if a coronary artery plaque ruptures (Kovala, 2005). A 10 year 
follow up study conducted in Japan found that low serum total cholesterol (<160 mg/dl) 
levels are associated with high mortality from intraparenchymal hemorrhage while high 
levels (>260 mg/dl) are associated with high mortality from coronary heart disease (Cui, 
Iso, Toyoshima, Date, Yamamoto, Kikuchi et al., 2007). 
 The level of cholesterol in blood can be increased by consuming a diet high in 
cholesterol and fat. Dietary cholesterol originates from meat, poultry, fish, seafood and 
dairy products.  There are three different kinds of dietary fats: saturated, polyunsaturated, 
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and monounsaturated (Perkins & Visek, 1983). Saturated fat is the main dietary cause of 
elevated blood cholesterol. Saturated fats are found predominately in foods from animal 
sources and in a few plant derived products, principally coconut and palm oils (Perkins & 
Visek, 1983). Polyunsaturated and unsaturated fats are found in fish, nuts, seeds and 
vegetable oils. Both polyunsaturated and monounsaturated fats may help to lower the 
blood cholesterol level when used to replace the saturated fats in the human diet. Along 
with cholesterol, saturated fats may cause arthrosclerosis (Perkins & Visek, 1983). There 
are currently several methods to treat coronary heart disease, including medications (such 
as beta-blockers and Ca channel blockers), non-surgical methods (such as angioplasty, 
atherectomy), and surgical methods (such as bypass and off-pump bypass). 
 Obesity has also been linked to elevated cholesterol levels, placing individuals at 
risk for a range of health issues including high blood pressure, diabetes, heart disease, 
and stroke. Physicians test cholesterol levels to determine how much cholesterol is 
carried by low density lipoproteins (LDL) and how much is carried by high density 
lipoproteins (HDL). Higher levels of HDL, the most preferred form of lipoproteins, do 
not occur with obesity, aid in lowering heart disease and stroke risks. (Smolak & 
Thompson, 2009). Obesity has become a very serious problem in America. One in three 
children or adults are considered to be obese. Children are less engaged in physical 
activity although many schools now have a mandatory implementation of physical 
education (Smolak & Thompson, 2009). In addition to genetic factors, unhealthy eating 
behavior and lack of physical activity are two major contributing factors of obesity. 
Gastric by-pass surgery is a last resort method to extreme obesity. However, gastric  
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by-pass surgery is not indicated for the obese individual who is unwilling to make long 
term dietary behavior changes (Blass, 2008). Therefore, preventing obesity is the best 
solution by maintaining healthy weight through diet and exercise. 
2.2 Cholesterol 
Cholesterol is a soft, fat-like, waxy substance found in blood serum and in 
somatic cells. Normal levels of cholesterol in blood serum are important because it is 
important in maintaining a healthy body. It is used for producing cell membranes and 
some hormones, and assists in other bodily functions such as, digestion and building 
muscle (Kovala, 2005). About 20–25% of total daily cholesterol production occurs in the 
liver; other sites of high synthesis rates include the intestines, adrenal glands, and 
reproductive organs. Major dietary sources of cholesterol include cheese, egg yolks, beef, 
pork, poultry, and shrimp (USDA, 2008). The amount of cholesterol present in plant-
based food sources is generally much lower than animal based sources (Behrman & 
Gopalan, 2005). Plant products such as flax seeds and peanuts contain cholesterol-like 
compounds called phytosterols, which help lower serum cholesterol levels by inhibiting 
absorption (Ostlund, Racette, & Stenson, 2003).  
 Cholesterol is synthesized in four different stages. Initially, 2 acetyl-CoA 
molecules condense to form acetoacetyl-CoA. A third acetyl-CoA is added and 
condenses to form 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) (The 
University of Bristol, 2007).  HMG-CoA is then reduced by HMG-CoA reductase to 
form mevalonate.  Mevalonate is decarboxylated to form isopentenyl pyrophosphate. 
Isopentenyl pyrophosphate is then condensed to form farnesyl pyrophosphate. Two 
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molecules of farnesyl pyrophosphate are then condensed to form squalene, which in turn, 
forms lanosterol, which is converted to cholesterol (Rhodes, Stryer, & Tasker, 1995). 
Bate, Rumbold, & Williams (2007) designed a basic flow chart of the synthesis of 
cholesterol (see Figure 2.1). 
 
 
Figure 2.1. Flow Chart of Cholesterol Synthesis  
 
 
Vehicles which transport cholesterol throughout the blood stream are known as 
lipoproteins. There are five main classes of lipoproteins: 1) very low density lipoproteins 
(VLDL), 2) intermediate density lipoproteins (IDL), 3) low density lipoproteins (LDL), 
4) high density lipoproteins (HDL), and 5) chylomicrons. In general, lipoprotein particles 
range in size from 10 to 100 nm. Lipoproteins are composed of a hydrophobic core 
containing cholesterol esters, triglycerides, fatty acids and fat-soluble vitamins. The 
surrounding hydrophilic layer is composed of various apolipoproteins, phospholipids, and 
cholesterol (Sigma-Aldrich, 2007). Chylomicrons are the largest but least dense of the 
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lipoproteins. They contain only 1-2% protein, 85-88% triglycerides, ~8% phospholipids, 
~3% cholesteryl esters and ~1% cholesterol. Chylomicrons are produced for the purpose 
of transporting dietary triglycerides and cholesterol absorbed by intestinal epithelia. 
Chylomicron assembly originates in the intestinal mucosa. VLDL’s are slightly smaller 
than chylomicrons in terms of size, density and lipid content. VLDL’s are approximately 
25-90 nm in size, with a density of ~0.98 and contain 5-12% protein, 50-55% 
triglycerides, 18-20% phospholipids, 12-15% cholesteryl esters and 8-10% cholesterol 
(Sigma-Aldrich, 2007).  
LDL contains 20-22% protein, 10-15% triglycerides, 20-28% phospholipids, 37-
48% cholesteryl esters and 8-10% cholesterol. HDL contains approximately 55% protein, 
3-15% triglycerides, 26-46% phospholipids, 15-30% cholesteryl esters and 2-10% 
cholesterol. LDL and HDL transport both dietary and endogenous cholesterol in the 
plasma. LDL is the main transporter of cholesterol and cholesteryl esters and makes up 
more than half of the total lipoprotein in plasma. LDL is absorbed by the liver and other 
tissues via receptor mediated endocytosis. The cytoplasmic domain of the LDL receptor 
facilitates the formation of coated pits; receptor-rich regions of the membrane (Sigma-
Aldrich, 2007). The recommended values for total cholesterol, LDL, and HDL are 
<200mg/dl, <100mg/dl, and >40mg/dl, respectively. The National Institutes of Health 
(NIH) has developed guidelines for healthy cholesterol levels (see Table 2.1). Following 
these guidelines, can help assist in a healthy lifestyle. These recommendations are of 
great importance because cholesterol levels have been used a biomarkers to determines 
the risk of cardiovascular diseases. 
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Table 2.1 
National Recommendations for Cholesterol  
Total Cholesterol 
<200 Desirable 
200-239 Borderline High 
>240 High 
LDL Cholesterol 
<100 Optimal 
100-129 Near Optimal/Above Optimal 
130-159 Borderline High 
160-189 High 
>190 Very High 
HDL Cholesterol 
<40 Low 
>60 High 
 
2.3 Hematology Values 
 Blood tests are one of the most important tools that can be used in evaluating 
health status.  There are serum chemistry tests available to evaluate major organ function 
along with normal blood levels for cholesterol. Liver function can be evaluated by testing 
for alanine transaminase (ALT). ALT is found in blood serum and in several body 
tissues, but is most commonly associated with the liver. It catalyzes two parts of the 
alanine cycle. ALT is currently one of the most reliable markers of hepatocellular injury, 
necrosis, and congestive heart failure (Giboney, 2005).  In rats the normal ALT values 
are dependent on the species of rat being studied. Kidney function may be evaluated by 
testing for levels of serum creatinine (Cr), blood urea nitrogen (BUN) and glucose 
(GLU). Creatinine is created from the chemical waste that is generated from the 
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metabolism of muscle in the body. High levels of creatinine can be an indicator of kidney 
dysfunction (Beard, Taylor, and Miller, 1957).  In humans, reference ranges of creatinine 
are 0.7 to 1.3 mg/dL in men and 0.6 to 1.1 mg/dL in women (Abcar, Chan, and Yeoh, 
2004). In rats, ALT values are species dependent.  
Pancreatic function may be evaluated by testing for normal glucose metabolism 
and amylase activity.  Amylase is involved in the breakdown of dietary starch into 
glucose. Glucose is the body’s main source of energy. Blood glucose levels are regulated 
by insulin and glucagon, hormones produced by the pancreas.   Insulin is released into the 
blood when the amount of glucose in the blood rises to dangerous levels and causes cells 
in the liver, muscle, and fat tissue to take up glucose from the blood, storing it as 
glycogen in the liver and muscle (Gibney, 2005).  When blood glucose levels are too low, 
glucagon is released to initiate the breakdown of glycogen. If glucose levels remain too 
high over time, diabetes can occur and may cause damage to the cardiovascular and renal 
systems (Gibney, 2005). Normal values of glucose for humans generally range from 70 to 
120 grams per deciliter (g/dL) and depend on factors such as weight, age, and 
environment (American Diabetes Association, 2006).  Amylase which is produced by 
pancreatic cells may be affected by abnormal pancreatic function.  Injury to the pancreas 
results in an increase in serum amylase levels.  
 Ammonia metabolism occurs in the liver where it is converted to BUN and then 
excreted by the kidneys. BUN measures the amount of nitrogen in the blood and is a way 
to measure renal function. Elevated BUN may be an indicator of moderate to severe renal 
failure. Low BUN levels are not as significant but can indicate a problem with the liver 
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(Gennari, 2001). As with the previous biochemical values, rat values are species 
dependent. In humans, the normal range is 10-15mg/dL (Gennari, 2001).  
2.4 Polyphenols 
Fruit, vegetable, and nut consumption have been associated with reduced risks of 
some forms of cancer, heart disease, stroke, obesity, and other chemical diseases. This is 
partially contributed to their antioxidant capability. Polyphenols are secondary 
metabolites of plants. Polyphenols contribute to the color and taste of many fruits and 
vegetables. Polyphenols can also exist in certain amounts in grains and legumes. 
Polyphenols are classified into different groups as a function of the number of phenol 
rings that they contain and the structural elements that bind these rings to one another. 
Distinctions can be made between the phenolic acids, flavanoids, stilbenes, and lignans. 
The flavanoids share a common structure consisting of two aromatic rings (A and B) that 
are bound together by three carbon atoms that form an oxygenated heterocycle (ring C). 
Flavanoids may be divided into six subclasses as a function of the heterocycle that is 
involved: flavonols, flavones, isoflavones, flavanones, anthocyanidians, and flavanols 
(catechins and proanthocyanidins). The most abundant flavanoids found in foods are 
flavonols, and the main representatives are quercetin and kaempferol. Red wine and tea 
contain up to 45mg/L of flavonols. For years, wine has been praised for its rich 
antioxidant properties. Flavonol compounds are present in the glycosylated form. Fruit 
often contains between 5 to 10 different flavonol glycosides (Clifford, 1999). 
 Flavonols accumulate in the outer and aerial tissues of plants where their 
biosynthesis is stimulated by light.  Concentration differences can exist between different 
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pieces of fruit on the same tree and even between different sides on one piece of fruit, 
depending on the level of exposure to sunlight (Price, Breen, Valladao, & Watson, 1995). 
Flavones are less common than flavonols in fruit and vegetables. Celery and parsley are 
the only important edible sources of flavones (Manach, Morand, Jime´nez, Rémésy, & 
Scalbert, 2004). Isoflavones are flavonoids with a very similar structure to estrogens. 
Although isoflavones are not steroids, they have hydroxyl groups in positions 7′ and 4′ in 
a configuration comparable to the hydroxyls in the estradiol molecule. Isoflavones have 
pseudohormonal properties on them, which includes the ability to bind to estrogen 
receptors. Isoflavones are also known as phytoestrogens. Isoflavones are found almost 
exclusively in legumes, particularly in soy beans (Manach et al, 2004). 
 Flavanols exist in both monomer form, which are catechins, and the polymer 
form, which are proanthocyanidins. Catechins are found in different types of fruit, such 
as apricots which are the richest source. Catechins are also present in red wine, but green 
tea and chocolate are by far the richest sources (Lakenbrink, Lapczynski, Maiwald, & 
Engelhardt, 2000). Proanthocyanidins, which are also known as condensed tannins, are 
dimmers, oligomers, and polymers of catechins that are bound together by links between 
C4 and C8 (C6) (Guyot, Marnet, Laraba, Sanoner, & Drilleau, 1998). Anthocyanins are 
the pigments that are dissolved in the vacuolar sap in the epidermal tissues of flowers and 
fruit (Mazza & Maniati, 1993). Anthocyanins are stabilized by the formation of 
complexes with other flavonoids. Anthocyanins are found in red wine, certain cereals, 
and certain leafy and root vegetables, but they are very abundant in fruit. Cyanidin is the 
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most common anthocyanidin in foods, especially in the skin of fruit (Manach et al., 
2004).   
Procyanidins are polyphenolic compounds that are usually found in pine bark 
(Rohdewald, 1998) grape (seeds and skin) (Escribano-Bailon, Gutierrez-Fernandez, 
Rivas-Gonzalo, & Santos-Buelga, 1998) cocoa, cranberries and apples (Hammerstone, 
Lazarus, & Schmitz, 2000). Monomeric procyanidins are polyhydroxyflan-3-ol 
monomers, and are often called catechins; which includes catechins, epicatechin, 
gallocatechin, epigallocatechin, and their gallic acid esters (catechins gallate and 
epicatechin gallate) (Yu et al., 2006). Lignans are formed of two phenylpropane units. 
The richest dietary source of lignans is linseed. Other cereals, grains, fruit and certain 
vegetables also contain traces of these same lignans, but concentrations in linseed are 
≈1000 times as high as the concentrations in other food sources (Adlercreutz, 1997). 
Stilbenes are found in low quantities in the human diet. One of these, resveratrol, for 
which anticarcinogenic effects have been extensively studied, is also found in low 
quantities in wine, grape skin, and peanut skin also contain a certain level of resveratrol 
(Bertilli et al., 1998; Bhat & Pezzuto, 2002; Vitrac, Vercauteren, Deffieux, & Mérillon, 
2002). The polyphenol fraction of wine includes phenolics acids, trihydroxy stilbenes, 
oligomer proanthocyanidins, and the flavonoids (Soleas & Goldberg 199; Salah, Miller, 
Paganga, Tijburg, Bolwell, & Rice-Evans, 1995). The antioxidant effectiveness of some 
of these polyphenolic compounds have been found to be more potent than vitamin E in 
their free radical scavenging properties in addition to their ability to prevent LDL 
oxidization (Nardini, Aquino, Tomassi, Gentilli, Felice, & Saccini, 1995). Grape seed 
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proanthocyanidins were found to possess cardioprotective abilities by functioning as an 
in-vivo antioxidant and their ability to directly scavenge reactive oxygen species 
including hydroxyl and peroxyl radicals (Sato, Maulik, Ray, Bagchi, & Das, 1999). 
 Additionally, there have been many studies that involve the health benefits of 
plant extracts. In one particular study, green tea was added to the diet of rats which 
included 1% cholesterol and 10% coconut oil to investigate the serum antioxidative 
activity of the polyphenols in green tea. Researchers found an increase in HDLs and 
decrease in total cholesterol due to polyphenol addition to diet of rats (Yokozawa, 2002). 
A study published in 2008, tested the polyphenols in peanut skins as a way to decrease 
cholesterol. The preliminary results showed a reduction in serum cholesterol levels in rats 
as a result of the addition of peanut skins to the diet (Shimizu-Ibuka, Udagawa, 
Kobayashi-Hattori, Mura, Tokue, Takita et al., 2009). These studies offer insight to the 
potential health benefits of polyphenols. 
2.5 Justification/Importance of the Study 
There are numerous studies that confirm the health effects of polyphenols in the 
diet. For instance in one Japanese study, the results suggested that polyphenolic 
substances derived from cocoa powder may contribute to a reduction in LDL cholesterol, 
an elevation in HDL cholesterol, and the suppression of LDL oxidation (Seigo, Midori, 
Akiko, Yuko, Takaaki, Naomi et al 2007). The first human study to find that a tea 
product lowers LDL cholesterol was completed by a researcher in Vanderbilt University 
Medical Center (Pasley, 2003). In this particular study, a 375 mg capsule made up of 75 
mg of theaflavins (flavanoids from black tea) 150 mg of catechins (flavanoids from green 
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tea) and 150 mg of other tea polyphenols was used instead of liquid tea. The ingredients 
of the capsule were equivalent to seven cups of high-quality black tea or 35 cups of green 
tea. The results of this study resulted in an overall reduction of LDL cholesterol by 16% 
(Pasley, 2003). 
 A study of blueberry consumption showed the cholesterol-lowering potential of 
blueberries was similar to that of effective drugs. The blueberries contain a compound 
pterostilbene, which is an antioxidant that is similar to resveratrol, another antioxidant 
identified in grapes and red wine that is also believed to lower cholesterol.  Many 
epidemiological studies have suggested that there is an association of red wine and the 
prevention of cardiovascular disease. The lower coronary heart disease mortality in 
France has been related to the high intake of red wine (Renaud & de Lorgeril, 1992.) 
Studies have indicated that the high content of polyphenolic components in red wine 
could be a key factor in the prevention of life-style related diseases (Belleville, 2002; Sun 
Simonyi, & Sun, 2002). 
 A large body of evidence consistently shows that consumption of tree nuts and 
peanuts is associated with a decreased risk of coronary heart disease. The Nurses’ Health 
Study showed an inverse association between nut consumption and the risk of coronary 
heart disease (Griel et al., 2004). It was reported that the substitution of fat from one 
ounce of nuts for the equivalent energy from carbohydrate and saturated fat reduced 
coronary heart disease risk by 30% and 45%, respectively (Hu & Stampher, 1999). The 
health benefits associated with nuts are thought to reflect their nutritional profile 
including their nutrient density, fatty acid profile, and presence of bioactive compounds.  
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A couple of the bioactive substances that are present in nuts are flavanoids and 
resveratrol which are known for their association with decreased cholesterol and coronary 
heart disease risks (Griel et al., 2004). The health benefits of red wine and grape seeds 
have been extensively studied. However, peanut skin is also rich in polyphenols. 
According to Yu et al. (2006), the red skin of peanuts contained 12-13% phenolics, which 
consisted of mainly A-type and B-type procyanidins. In addition, peanut skin also 
contains certain amounts of protein, fat/lipid and non-digestible carbohydrates. In vitro 
studies have shown that peanut skin polyphenols have 2-3 times the antioxidant activity 
of vitamin C (Yu et al., 2006).  It is important to investigate the health benefits of peanut 
skin and peanut skin polyphenols in vivo using animal models. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Peanuts and Peanut Skin Removal 
 Raw peanuts were obtained from Peanut Processor’s in Dublin, North Carolina. 
Peanut kernels were frozen overnight. Then the skins were removed manually by the 
direct peeling method. The peanut skins were dried in a Fischer Scientific Isotemp 
vacuum oven and ground into a powder using a Retsch PM100 Ball Mill (Haan, 
Germany). 
3.2. Proximate Composition of Peanut Skins 
Crude Fiber Analysis: The crude fiber in peanut skin was determined by AOCS 
method Ba 6-84, AOAC 962.09 (Filter Bag Technique) using an Ankom 200 Fiber 
Analyzer (Macedon, New York) using the procedures in the Ankom manual. The 
procedures include fat extraction steps (acetone,), acid hydrolysis, alkaline hydrolysis, 
drying and ashing. This method determines the organic residue after digesting with 
0.255N H2SO4 and 0.313N NaOH. The analysis was conducted in triplicate. Detailed 
procedures are described below.  
 Filter bags were weighed (W1) before adding samples, then 0.95-1.00 g peanut 
skin (W2) powder was directly weighed into each filter bag. A blank bag was weighed 
and included in run to determine blank bag correction (C1). The bags were then sealed 
using a heat sealer, placed into a 250 ml container, and then acetone was added to the 
container to extract fat from peanut skin samples. Acetone was added in the container just 
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enough to cover the bags. The container was then secured with a lid and soaked for 10 
minutes. This process was repeated one additional time with fresh acetone.  
After the acetone was poured out, the bags were placed on a wire screen to dry. 
The dry bags were placed on a bag suspender tray and the tray was then submerged in a 
vessel containing 1950ml of 0.225N H2SO4 solution. The vessel was tightly sealed with a 
lid. Samples in the bags were extracted for 45 minutes under heat and agitation. At the 
end of extraction the agitator and heat were turned off. The exhaust valve was opened and 
the hot solution was released before opening the lid. After the solution had been 
exhausted, the exhaust valve was closed and then the lid was opened. Following the rinse, 
1950ml of 95°C water was added to rinse the bags for 3 minutes with agitation. The lid 
was closed but not completely tightened. The rinse was repeated two additional times. 
1950ml of 0.313M of NaOH was added to the vessel with agitation and heated for 45 
minutes. After going through the same process as that with 1950 ml of 0.225 N2SO4, the 
bag was rinsed three times as described above. This process was repeated two additional 
times.  
The filter bags were removed from the suspender trays and the water was gently 
pressed out to remove excess water. The bags were soaked in acetone for two minutes, in 
a 250 ml beaker, then removed and pressed gently to remove any excess acetone.  The 
bags were spread out to dry by air. The dry bags were then placed in an oven at 105°C for 
two and a half hours. The bags were removed from the oven and placed in desiccant 
pouches until cooled to ambient temperature and weighed (W3). The ash was placed in a 
pre-weighed crucible and placed in a furnace for two hours at 550°C. The ash was then 
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cooled in desiccators and weighed for the organic matter calculation. Percentage of crude 
fiber in each sample is calculated as follows: 
% Crude Fiber = 100 x (W3 - (W1 x C1))/W2 
Where, W1= bag weight, W2= sample weight, W3 = weight 
of organic matter, C1= ash corrected blank bag factor 
Crude Protein Analysis: The crude protein content in peanut skins was 
determined by the AOAC method 990. 03 (AOAC, 1990) utilizing a Leco Truspec CN 
Analyzer (Leco Corporation, St. Joseph, MI). This is a combustion based elemental 
analyzer. For protein determination, it measures percent of total nitrogen after sample is 
completely combusted. The conversion factor of 6.25 was used to convert percent N to 
percent protein. The machine was calibrated using EDTA powder which contains 9.2% 
nitrogen. Powdered peanut skin sample was weighed in a special aluminum foil 
(0.1500g). The sample was wrapped and placed in an auto-sampler tray. After entering 
sample information (name, weight, and conversion factor) in the computer, the analyzing 
cycle started by clicking Analyzer button from computer. The computer calculated the 
percent protein automatically according to the nitrogen detected and sample information 
entered. Protein determination of peanut skins was conducted in triplicate.  
Crude Fat Analysis: This analysis was done utilizing the Foss Soxtec 2050 
Extractor (Foss, Eden Prairie, Minnesota). The analysis was conducted in four 
replications. Four samples of powdered peanut skin each 2.00g were weighed (W1) into 4 
thimbles.  After the extractor was turned on along with the heater, the thimbles were 
placed in thimble holders and loaded into the extractor. Then the extraction cups (W2) 
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each containing 60 ml of petroleum ether were loaded in the machine. When the 
extraction cycle started, thimbles containing samples were submerged in heated 
petroleum ether. When the cycle ended, the thimbles and extraction cups were removed. 
Extraction cups contained fat extracted. Cups were weighed (W3), and the weight 
differences before and after extraction were the fat weight.  Percent fat in peanut skin was 
calculated by following equation: 
% Fat =   (W3-W2) x 100 / W1 
Where, W1= peanut skin sample weight, W2= weight of empty cup, W3 = weight of cup 
containing extracted fat. 
3.3 Extraction and Determination of Phenolics in Peanut Skin  
 Extraction of phenolics: Eighty percent ethanol was used to extract phenolics 
from the peanut skin. Thirty millimeters of solvent was added in a 50ml centrifuge tube 
containing 1.000g of peanut skin. The mixture was homogenized by using a PT2100 
Polytron Homogenizer (Brinkman, Switzerland) for 2 minutes, and then centrifuged at 
3000g for 15 minutes at room temperature.  The volume (v) of combined supernatant was 
collected in an amber bottle. The precipitate was extracted twice by the same procedure 
described above. The volume of combined supernant was measured and filtered through a 
Whatman Anotop syringe filter (0.2µm) and stored in a freezer until use. The extraction 
of the peanut skins was performed in triplicate.  
Phenolics Determination: The determination of total phenolics was completed by 
using the Folin-Ciocalteu method (Singleton et al., 1999). Briefly, 20µl of sample 
solution or standard solution was added to a 4 ml glass vial, followed by adding 1.28ml 
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of distilled water and 100µl of Folin-Ciocalteau reagent (Sigma-Aldrich, St. Louis, MO). 
The mixture in the vial was mixed using a Vortex and left at room temperature for 8 
minutes. Then, 0.6ml of the Na2CO3 solution was added. The vial was capped and left at 
room temperature in the dark for 2 hours. The absorbance of the sample was measured at 
765nm using a Genesis 10 Spectrometer (Fisher Scientific). Four replications were 
conducted. The determination was conducted in four replications. 
Gallic acid (Sigma-Aldrich, St. Louis, MO) was used as the standard to develop 
standard curve according to the procedure described above. Total phenolics (mg/ml) in 
the extract was calculated using a calibration curve developed using a set of gallic acid 
solutions with known concentrations (0-100 mg/ml), and the result was expressed as a 
gallic acid equivalent (GAE) (mg gallic acid/ml extract). The phenolic concentration of 
the peanut skin powder was calculated as follows:  
Phenolic Content (mg/g) = total phenolics (mg/ml) x (v) (ml)/sample weight (g) 
3.4 Animal Experiment  
Experimental Design: Twenty-five seven week old Sprague Dawley rats were 
obtained from Harley Sprague-Dawley, Inc (Indianapolis, Indiana). On arrival to North 
Carolina Agricultural and Technical State University, all animals were subjected to a 
physical examination by the technical staff under direction of the clinical veterinarian to 
ensure satisfactory health status. Rats were randomly divided into five groups.  Rats 
received one of five experimental diets,  G1- standard Purina 5001 rodent diet; G2- 
Purina-5001 + 1% cholesterol; G3- Purina-5001 + 1% cholesterol and 2.5% peanut skin, 
G4- Purina-5001 + 1% cholesterol and 5.0% peanut skin; and G5- Purina-5001 + 1% 
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cholesterol and 10.0% peanut skin. Table 3.1 shows the calculations for the inclusion of 
peanut skin powder for each of the five diet groups.  
Table 3.1  
 
Calculation of Feed with the Inclusion of Peanut Skin Powder 
 
Groups 
Peanut Skin 
Powder (g) 
Rodent Chow (g) Total Feed (g) 
G1 0 1000 1000 
G2 0 1000 1000 
G3 25 975 1000 
G4 50 950 1000 
G5 100 900 1000 
Note. G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4-control + 1%  
          cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin 
 
Housing condition: Rats were housed in individual stainless steel suspended wire 
mesh cages in a room maintained at 21± 3ºC, 50±10% humidity, with 12 hour light-dark 
cycles. After a seven-day adaptation period all rats were fed one of the experimental diets 
for eight weeks.  All animals were maintained in accordance with university animal care 
policy regulations.   
Measurement of feed consumption and weight gain of rats during feeding period: 
The animals were offered 100g of feed initially. The animals feed was weighed every two 
days. Their feed consumption was calculated by subtracting the amount left in the feeding 
cups by the amount offered. The animals were weighed weekly using an Arbor 1605 
balance. Their weight gain was calculated by subtracting the current weight from the 
previous weekly weight.  
Blood Collection: The animals were placed in an inhalation chamber and 
anaesthetized by inhalation of 1% isoflurane. Blood was collected retro-orbitally from the 
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animals for weekly analysis. The amount of blood collected from each animal varied 
based on the animals health and availability of blood. Blood was collected in heparinized 
micro-hematocrit capillary tubes placed on a hematology mixer. Once the samples were 
analyzed, the remaining blood samples were stored in a -20ºC freezer.  
Evaluation of major organ functions by hematological analysis: Hematological 
analysis was performed utilizing the Abaxis VetScan HM II Hematology analyzer from 
TW Medical Veterinary Supply (Lago Vista, Texas). The rotors used were the 
Comprehensive Diagnostic Profile from Abaxis. The blood used for the analysis was 
pooled from each animal of that corresponding treatment group. The amount of blood 
needed was 100µl. The blood chemistry profile included Alanine Transferase, (µ/l), 
Amylase (µ/l), Blood Urea Nitrogen (mg/dl), Creatinine (mg/dl), Glucose (g/dl), Total 
Protein (g/dl).   
Blood lipid profile: The cholesterol profile of rat blood was performed utilizing 
the Abaxis VetScan II Blood Chemistry Analyzer from Abaxis (Union City, California). 
The rotors used were Lipid Panel Reagent Disc from TW Medical Veterinary Supply 
(Lago Vista, Texas). Blood samples of five rats in the same treatment group were pooled 
and used for analysis. The amount of blood needed for each group was 100µl. The items 
analyzed were total cholesterol (TC) (mg/ml), high density lipoprotein (HDL) (mg/ml), 
low density lipoprotein (LDL) (mg/ml), very low density lipoprotein (mg/ml) (VLDL), 
and triglycerides (TG) (mg/ml). 
Necropsy: Animal necropsy was performed for gross examination for 
pathological change and organ weight analysis. The heart liver, spleen, adrenal glands, 
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ovaries, brain, thymus, and lungs were all weighed. All organs were stored in 10% 
buffered formalin.  
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CHAPTER 4 
RESULTS AND DISCUSSIONS 
4.1 Proximate Composition of Peanut Skin and Feed 
 
 The composition of the peanut skins was very important to this study. This 
analysis was necessary to determine if the inclusion of peanut skin in the rat feed could 
cause significant change in the diet composition of the rat diet. Table 4.1 shows 
proximate compositions of peanut skin and original rat feed. The peanut skin contained 
19.41% fiber, 16.60% fat, 12.32% protein, 2.83% ash. 
Table 4.1 
 
Proximate Composition and Total Phenolics of Peanut Skin Used  
 
 
Component 
 
% Fiber 
 
% Fat 
 
% Protein 
 
% Ash 
Total 
Phenolics  
(mg/g skin) 
 
 
Content 
 
 
19.41 
 
 
16.60 
 
 
12.32 
 
 
2.83 
 
 
 
7.29 + 0.26 
 
 
The inclusion of peanut skin in the rat feed at 2.5-10% did not cause significant 
changes in feed protein content, but resulted in increased total fat and fiber, and 
decreased ash content in the feed. The inclusion of peanut skin at the level of 2.5, 5.0 and 
10.0% also contributed 0.18, 0.36 and 0.73% of total phenolics to the rat feed, 
respectively as shown in Table 4.2. 
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Table 4.2  
 
Compositions of Feed Containing 0, 2.5, 5.0 and 10.0% Peanut Skin 
 
 
Groups 
% 
Replacement 
% 
Cholesterol 
% 
Fiber 
% 
Fat 
% 
Protein 
% 
Ash 
% 
Polyphenol 
G1 0 0 5.10 5.70 23.90 7.00 0 
G2 0 1 6.00 4.50 23.00 8.00 0 
G3 2.5 1 6.33 4.80 22.73 7.87 0.18 
G4 5.0 1 6.67 5.11 22.47 7.48 0.36 
G5 10 1 7.34 5.72 21.93 7.48 0.73 
Note. G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4-  
          control + 1%cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0%  
          peanut skin 
 
4.2 Feed Consumption and Weight Gain/Change as Affected by Peanut Skin 
 
Figure 4.1 shows the feed consumption among different feed groups throughout 
the eight week testing period. Figure 4.1 also shows that G5 had the highest food 
consumption among the different groups during the feeding period. In contrast, G1 had 
the lowest average feed consumption during the feeding period. This was to be expected 
because G1 did not have the addition of peanut skin powder to its diet.  This could be 
attributed to the palatability of the peanut skin powder that was added to the feed.  G3 
and G4 also had relatively low average food consumptions. From the results of the chart, 
there were no major differences in the consumption patterns of feed between the groups. 
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Figure 4.1. The Effects of peanut skin polyphenol on feed consumption 
 
When viewing Figure 4.1 note that G1-Control; G2-Cholesterol; G3- control +1% 
cholesterol + 2.5% peanut skin; G4- control + 1%cholesterol + 5.0% peanut skin; G5- 
control + 1% cholesterol + 10.0% peanut skin.  
4.2.1 Weight Changes of Rats During Feeding Period. As can be seen in Figure 
4.2, G1 has the lowest average weight. It does appear that G2 and G5 have the highest 
body weights. Referencing back to Figure 4.1, G1 has the lowest average food 
consumption; G2 and G5 have the highest average food consumption rates. The food 
consumption rates can be a contributing factor in the noticeable weight gain of the rats in 
G2 and G5.   When viewing Figure 4.2 note that G1-Control; G2-Cholesterol; 
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G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 1%cholesterol + 5.0%  
peanut skin; G5 control + 1% cholesterol + 10.0% peanut skin. 
 
Figure 4.2. Effects of different diets on the average weights of rats during the 8 week    
                   feeding period  
 
 
The presence of percent cholesterol in the diet could be an attributable factor for 
the  large body weight of rats in the treatment Groups (G2 to G5) and the addition of 
peanut skin slightly leveled off the weight gain of rats (G3 to G4). The largest average 
weight gain was observed in group 5, which was corresponded to the highest feed 
consumption (see Table 4.3). Therefore, it is possible that the addition of peanut skin in 
the diet may be able to control weight gain caused by the addition of cholesterol to the 
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diet. Under the experiment condition, adding up to 10% of peanut skin to the diet did 
assist in suppressing the weight gain of the rats.  
Table 4.3  
Weight Gain from Week 0 through Week 8 
 
Groups  
W1-
W0 
W2-
W0 
W3-
W0 
W4-
W0 
W5-
W0 
W6-
W0 
W7-
W0 
W8-
W0 
Average 
Weight (g) 
G1 5.24 9.94 23.56 32.16 40.48 38.08 45.14 32.58 28.40 
G2 11.26 22.3 36.22 42.38 49.88 52.44 56.76 48.92 40.02 
G3 12.82 25.52 28.38 31.2 39.2 47.76 52.8 47.48 35.65 
G4 12.32 21.46 28.46 33.82 43.84 52.5 56.22 48 37.08 
 
G5 22.82 28.46 36.96 41.36 52.64 57.38 56.48 44.82 42.62 
Note. G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4-  
          control + 1%cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0%  
          peanut skin 
 
 
4.2.2 Blood Chemistry Profile. The blood chemistry tests performed did not 
show any abnormal results for the parameters analyzed. All of the test results were within 
normal ranges for Alanine Transaminase (ALT), Blood Urea Nitrogen (BUN), Creatinine 
(CRE), Amylase (AMY), total protein (TP) and Glucose (GLU), as seen in Figures 4.3, 
4.4, 4.5, 4.6, 4.7, and 4.8 respectively. ALT is found in blood serum and in several body 
tissues including liver, lung, pancreas, kidney, heart, and muscles; but, is most commonly 
found with the liver. Please note the following while reviewing Figure 4.3, G1-Control; 
G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 
1%cholesterol + 5.0%  peanut skin; G5 control + 1% cholesterol + 10.0% peanut skin. 
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Figure 4.3. Effect of peanut skin contents in the diet on Alanine Transaminase  
 
ALT is currently one of the most reliable markers of hepatocellular injury, disease 
or necrosis. Additionally, ALT is used as a bio-marker for many different disorders such 
as fatty liver (Bose, Alvarenga, Tejero, Voruganti, Proffitt, Freeland-Graves, et al 2009).  
The increase of ALT may be an indication of liver damage or disease. Figure 4.3 shows 
that peanut skin containing diets did not change the ALT over the study period compared 
to the control group G1. We can conclude that during the period of this study (eight 
weeks), ALT values were not high enough to indicate liver damage or necrosis. 
BUN measures the amount of nitrogen in the blood and is an efficient way to 
measure renal function. Elevated BUN may be due to kidney disease as well as 
congenital heart failure. Low BUN may be due to liver failure or malnutrition/over 
hydration (Gennari, 2001). According to the BUN value of rats in control group 1 (G1), 
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the normal BUN range for rats should be 14.3-19.9 mg/dl, with the exception of a few 
data points (see Figure 4.4).  
Figure 4.4 indicated that the peanut skin powder could have an effect on the BUN 
levels. Over time, the groups with the addition of peanut skin had lower levels of BUN. 
Again, the levels of BUN could be attributed to the high food consumption during the 
feeding period as seen in Table 4.4. There was not an increase in protein in the diet or 
decrease in fluid intake to explain the inconsistencies in BUN measures. Perhaps the 
pooled blood might explain these changes in BUN.  Note that G1-Control; G2-
Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 
1%cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin. 
Creatinine is created from the chemical waste generated from the metabolism of 
muscle in the body. Creatinine is also measured with BUN to identify kidney 
dysfunction. High levels of creatinine can be an indicator of kidney dysfunction (Beard et 
al., 1957). Creatinine levels rise when the kidneys are not working properly. The normal 
range of Creatinine is 0.3-0.5 (mg/dl). Figure 4.5 shows the creatinine levels of groups 
over the study period. The finding from this analysis indicates that the creatinine levels 
could have been measured inaccurately, which could explain the unpredictable trend in 
the data points. The incorrect measurement could be either computer or human error. 
Note that G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; 
G4- control + 1%cholesterol + 5.0%) peanut skin; G5- control + 1% cholesterol + 10.0% 
peanut skin. 
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Figure 4.4. Effect of peanut skin contents in the diet on Blood Urea Nitrogen  
 
 
 Glucose is derived from the carbohydrates in foods and is the main source 
of energy used by the body. The normal blood glucose levels in rat is 76- 147 (mg/dl). 
Figure 4.6 shows the blood glucose levels of rats from the different treatment groups 
taken during the study period. Blood glucose levels of rats in the treatment groups G3, 
G4 and G5 were not different from that in control groups G1 and G2. Therefore, 
inclusion of peanut skin in the rat diet up to 10% does not appear to cause a negative 
effect on rat blood glucose levels and presumably does not impact kidney function. Note 
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that G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- 
control + 1%cholesterol + 5.0%) peanut skin; G5- control + 1% cholesterol + 10.0% 
peanut skin. 
 
Figure 4.5. Effect of peanut skin contents in the diet on Creatinine 
 
 
 
 
 
  34 
Figure 4.6. Effect of peanut skin contents in the diet on the blood glucose of rats  
 
 
Amylase is an enzyme that aids in the digestion of carbohydrates (Owyang, 
2007). It is produced in the pancreas and the salivary glands. Amylase production can be 
a biomarker for diseases of the pancreas. The normal range for rats is 720-817 (u/l). 
Figure 4.7 shows the amylase levels of rats from the different treatment groups over the 
study period. High cholesterol diet resulted in higher blood amylase (G2) and the 
inclusion of peanut skin in the high cholesterol diet did not show consistent effect on the 
blood amylase level. For example, amylase in the G1 and G3 were consistently lower 
than G2. However, G4 and G5 were not. Please note that G1-Control; G2-Cholesterol; 
G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 1%cholesterol + 5.0% 
peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin. 
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 Figure 4.7. Effect of peanut skin contents in the diet on amylase of rats   
 
Total blood protein is used as a biomarker for liver dysfunction and nutritional 
problems (Bazari, 2007). Figure 4.8 shows that the normal range for rats is 7-7.7 (g/dl). 
Consumption of high cholesterol diet (G2) appeared to elevate total protein, but inclusion 
of peanut skin in the high cholesterol diet showed a lower total blood protein with 
exception of G4.  The reader should note that G1-Control; G2-Cholesterol; G3- control 
+1% cholesterol + 2.5% peanut skin; G4- control + 1%cholesterol + 5.0% peanut skin; 
G5- control + 1% cholesterol + 10.0% peanut skin. 
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Figure 4.8. Effect of peanut skin contents in the diet on total protein of rats   
 
 
The reason that rats in group four had higher total protein in the blood is 
unknown. Because total protein (TP) analysis was done using pooled blood samples, if 
one rat had very high blood TP, the results of the whole group would be affected. 
Therefore, a better design study is needed to confirm the result presented here. 
4.2.3 Blood Lipid Profile. The items analyzed were total cholesterol (TC), high 
density lipoprotein (HDL), low density lipoprotein (LDL), triglycerides (mg/ml), the ratio 
of (TC/HDL) and very low density lipoprotein (VLDL). The cholesterol profiles are very 
important because they are risk indicators of certain cardiovascular diseases such as 
stroke and heart disease. Total cholesterol is tested as a preventative measure against 
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cardiovascular disease. The more elevated the TC levels are the higher the risk for plaque 
to build up on the artery walls and to cause health problems with the cardiovascular 
system such as stroke and heart disease (Welson, 2006).  The normal range of TC in rat 
blood is 81.7-123.9.  The results from the study are within normal limits.  
Figure 4.9 shows the TC levels of the different groups of rats over the study 
period. From the results of Figure 4.9, it appears that there were no differences among the 
groups. Not surprisingly, G1 which did not include extra cholesterol in the diet had the 
lowest levels of serum cholesterol. Compared with rats from G2, rats in the peanut skin 
containing diets had lower total cholesterol levels, particularly at later feeding stages, 
except those in G4. It would have been expected that the rats would have a decrease in 
their serum cholesterol based on the increasing amount of peanut skin added. Note that 
(G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5%  peanut skin; G4- 
control + 1%cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0% 
peanut skin. 
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Figure 4.9. Effect of diet with peanut skin polyphenol on Total Cholesterol level of     
                   rat sera  
 
The groups with the highest amount of peanut skin added did not consistently 
have the lower cholesterol levels. Additionally, the blood cholesterol levels could be 
attributed to the amount of food consumed as well; Figure 4.1 displays that G5 had the 
highest food consumption among the groups with the added cholesterol and peanut skin 
powder during the trial period. The total blood cholesterol of rats in G5 was high at an 
early stage of feeding but decrease significantly at later stage of feeding. These results 
indicate that long term feeding of peanut skin could offset the cholesterol level caused by 
high cholesterol diets. 
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The main function of HDL is to assist with the removal of excess cholesterol from 
within walls of the blood vessels and then carry it to the liver, where it is then broken 
down and removed from the body in the bile. Low levels of HDL can be an indicator of 
an increased risk for cardiovascular disease (Catapano, Bernini, and Corsini, 1993). 
According to the HDL of G1 (see Figure 4.10) the normal range of HDL for rats is 59.7-
70.7(mg/ml). Figure 4.10 shows that feeding high cholesterol diet resulted in significant 
decrease of HDL in experimental rats (G2). HDL level increased gradually in the 
treatment groups fed with 5 and 10% peanut skin. Therefore, we can assume if the rat 
with low blood HDL stop consuming high cholesterol diet but continued peanut skin diet, 
the HDL level will increase. When viewing Figure 4.10 note that G1-Control; G2-
Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 
1%cholesterol + 5.0%  peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin. 
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Figure 4.10. High Density Lipoprotein of rats in different treatment groups 
 
 
Triglycerides are the chemical form of fat exists in food as well as in the body. 
Triglycerides are also present in the blood plasma and are also associated with blood 
cholesterol in the form of plasma lipids. Calories that are ingested during a meal and not 
immediately used by the body tissues are converted to triglycerides and then transported 
to fat cells to be stored. Triglycerides in blood are often tested as a preventative measure 
against cardiovascular disease. Having high triglyceride levels can cause an increased 
risk for cardiovascular disease however there are no apparent consequences for low 
triglyceride levels (Welson, 2006). Figure 4.11 shows the Triglyceride results from the 
different groups over the study period. Based on the controls the normal range of 
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triglycerides in rat blood is 52.4- 92.7(mg/dL). The results show that adding 1% 
cholesterol to the diet significantly increased the blood triglyceride levels of rats in G2.  
The reader should note that G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 
2.5% peanut skin; G4- control + 1%cholesterol + 5.0%  peanut skin; G5- control + 1% 
cholesterol + 10.0% peanut skin. 
 
Figure 4.11. Triglyceride levels of rats in different treatment groups  
 
However, the addition of peanut skin did have a positive effect on the triglyceride 
levels. The triglyceride levels of rats in all treatment groups and control group reached 
their highest level between feeding week four and week five, and then exhibited a 
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declining trend. All rats fed peanut skin containing diets had lower blood triglyceride 
levels. Rats in G5 had the lowest levels of blood triglycerides corresponding to the 
highest level of peanut skin powder added. G2 that had the additional cholesterol and no 
peanut skin had the highest levels of triglycerides, with the control close behind. 
Therefore, peanut skin effectively reduced the serum triglyceride level of rats fed a 
cholesterol containing diet. Adding peanut skin in rat diet may significantly reduce blood 
triglyceride in human which may reduce the risk for cardiovascular disease.  
Figure 4.12 shows the ratio of Total TC/HDL of rats in different groups during 
the study. No significant difference in TC/H was observed among the treated groups, 
with the exception of G1. The results among the groups with the peanut skin did not 
show that the addition of peanut skin made a difference in TC/HDL ratio. Although the 
addition of peanut skin in the diet resulted in relatively low HDL levels as shown in 
Figure 4.10, the lower total cholesterol levels in rats fed with diet containing larger 
amounts of peanut skin polyphenol (see Figure 4.9) offset the TC/H ratios of rats in 
peanut skin fed groups. Adding 1% cholesterol to the diet did increase the TC/HDL of G2 
due to the increase of TC and decrease of HDL. The addition of peanut skin in the diets 
did not affect the TC/HDL until week four. After week four, TC/HDL began to decrease 
corresponding due to the decrease of TC (see Figure 4.7) and the increase of HDL (see 
Figure 4.8). The reader should note the following for Figure 4.12 G1-Control; G2-
Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 1% 
cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin. 
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Figure 4.12. TC/HDL of rats in different treatment groups  
 
 
LDL is measured to aid in the determination of the risk for cardiovascular disease. 
When LDL levels are considered to be too elevated, the risk for cardiovascular disease is 
increased; when the LDL levels are lowered the risks for cardiovascular diseases are 
decreased (Myant, 1990). The normal range for LDL in healthy rats is 8.8-14.9(mg/dL) 
based on the data from the control group. The blood LDL levels of treatment groups were 
out of the normal range. Figure 4.13 shows changes of serum LDL in the different groups 
during the eight week experimental period. Note that G1-Control; G2-Cholesterol; G3- 
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control +1% cholesterol + 2.5% peanut skin; G4- control + 1%cholesterol + 5.0%  peanut 
skin; G5- control cholesterol + 10.0% peanut skin. 
 
Figure 4.13. Low Density Lipoprotein of rats in different treatment groups   
 
Data show that rats fed with cholesterol containing diet had significantly higher 
LDL levels in their blood sera than rats in the control group. Higher peanut skin inclusion 
appeared to increase blood LDL of rats during the first four weeks of feeding; this might 
be due to the higher consumption of feed and cholesterol shown in Table 4.1. When the 
content of peanut skin in the diet was low (2.5% G3), no difference in LDL between rats 
in G2 and G3 was observed. However, from week five, LDL of rats in treatment Groups 
G3, G4 and G5 began to decrease. Therefore, for peanut skin to exhibit its health benefits 
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due to higher fiber and polyphenol content, it takes at least four to five weeks of 
continuous feeding. 
Figure 4.14 shows the blood VLDL levels of rats from the different groups over 
the experimental period. Data show some distinct differences amongst the groups. It 
appears that the addition of peanut skin may have a positive effect on the VLDL levels. 
G5 with the highest level of added peanut skin powder had the lowest levels of VLDL. 
G2 that had the additional cholesterol but no peanut skin had the highest levels of VLDL, 
with the control closely behind. Recent studies (Sarwar, Aspelund, Eiriksdottir, Gobin, 
Seshasai, Forouhi et al 2010; Mora, Otvos, Rifai, Rosenson, Buring, and Ridker, 2009) 
have found that VLDL played an important role in the development of cardiovascular 
diseases. Therefore, the VLDL cholesterol lowering effect of peanut skin is important in 
the reduction the risk of cardiovascular diseases risks. Note the following while 
reviewing Figure 4.14, G1-Control; G2-Cholesterol; G3- control +1% cholesterol + 2.5% 
peanut skin; G4- control + 1%cholesterol + 5.0% peanut skin; G5- control + 1% 
cholesterol + 10.0% peanut skin. 
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Figure 4.14. Very Low Density Lipoprotein of rats in different treatment groups  
 
 
4.2.4 Animal Organ Weights. The organs that were examined at necropsy were 
the spleen, heart, kidneys, brain, adrenal glands, lungs, and liver. Figure 4.15 shows that 
the average organ weight of rats in group 2 (G2) was higher than that of rats in group G1. 
Adding 5-10% of peanut skin in diets (G4 and G5) suppressed organ enlargement caused 
by the presence of cholesterol. For example, the average liver weights of rats in G4 and 
G5 were 5.3% and 10.6% lighter in weight than that of rats in G2. The kidney weights of 
G4 and G5 was 7.9 and 3.4% lighter in weight than that of G2, respectively. The spleen 
weights of G4 and G5 were 12.8 and 10.5% lighter than that of G2. Therefore, long term 
consumption of high peanut skin diet may have beneficial effects on the prevention of 
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fatty organs or organ enlargement. The percent weight change of each type of organ was 
calculated as follows: 
Percent change = (organ weight ofG3 or G4 or G5 - organ weight of 
G2)*100/organweight of G2 
The reader should note the following while viewing Figure 4.15 G1-Control; G2-
Cholesterol; G3- control +1% cholesterol + 2.5% peanut skin; G4- control + 
1%cholesterol + 5.0% peanut skin; G5- control + 1% cholesterol + 10.0% peanut skin. 
 
Figure 4.15. The effect of peanut skin diet on average organ weights at necropsy 
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CHAPTER 5 
CONCLUSION 
This study found that feeding female rats with peanut skin containing diet: (1) did 
not inhibit the growth of the rats; (2) reduced serum triglyceride; (3) reduced total 
cholesterol; (4) reduced VLDL cholesterol; and (5) suppressed organ enlargement caused 
by the high cholesterol diet. Adding peanut skin in the diet also appeared to improve the 
functions of liver, kidney, and pancreas as reflected by the better blood ALT, BUN, 
amylase and protein levels of rats in peanut skin diets. However, the study also found that 
inclusion of peanut skin in the rat diet resulted in higher LDL and lower HDL levels in 
the blood samples taken in the first four to five weeks of feeding period. This is 
controversial with the majority of published studies since consumption of polyphenol rich 
foods tends to reduce blood LDL and increase HDL. The age of rats used in this study 
might be a contributing factor of such controversy. In addition, because all blood 
chemistry and lipid profile analysis was done using pooled blood samples of the rats in 
the same treatment group due to the lack of experimental resources, it hard to tell if some 
of the data were outliers.  Therefore, more studies are needed to confirm these important 
findings. Further, studies are also needed to evaluate the lipid lowering effect of peanut 
skins as affected by gender and age of rats.   
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